These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 24608651)

  • 1. [Clinical review of 33 cases of rhinitis medicamentosa by decongestant nasal spray].
    Yuta A; Ogawa Y
    Arerugi; 2013 Dec; 62(12):1623-30. PubMed ID: 24608651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Rhinitis medicamentosa in cytological assessment of the nasal mucosa].
    Tarchalska B; Gotlib T; Samoliński B
    Pol Merkur Lekarski; 2005 Sep; 19(111):288-90. PubMed ID: 16358845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The rebound of nasal resistance after decongestant used in nose].
    Shen J; Huang X; Xiang J; Shu H
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1999 Dec; 13(12):560-1. PubMed ID: 12541428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term use of oxy- and xylometazoline nasal sprays induces rebound swelling, tolerance, and nasal hyperreactivity.
    Graf P
    Rhinology; 1996 Mar; 34(1):9-13. PubMed ID: 8739860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rebound congestion and rhinitis medicamentosa: nasal decongestants in clinical practice. Critical review of the literature by a medical panel.
    Mortuaire G; de Gabory L; François M; Massé G; Bloch F; Brion N; Jankowski R; Serrano E
    Eur Ann Otorhinolaryngol Head Neck Dis; 2013 Jun; 130(3):137-44. PubMed ID: 23375990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-week use of oxymetazoline nasal spray in patients with rhinitis medicamentosa 1 year after treatment.
    Graf P; Hallén H
    ORL J Otorhinolaryngol Relat Spec; 1997; 59(1):39-44. PubMed ID: 9104748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of the effect of nasal steroid sprays in perennial allergic rhinitis patients with rhinitis medicamentosa.
    Ferguson BJ; Paramaesvaran S; Rubinstein E
    Otolaryngol Head Neck Surg; 2001 Sep; 125(3):253-60. PubMed ID: 11555762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rhinitis medicamentosa: therapeutic effect of diode laser inferior turbinate reduction on nasal obstruction and decongestant abuse.
    Caffier PP; Frieler K; Scherer H; Sedlmaier B; Göktas O
    Am J Rhinol; 2008; 22(4):433-9. PubMed ID: 18702912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxymetazoline nasal spray three times daily for four weeks in normal subjects is not associated with rebound congestion or tachyphylaxis.
    Watanabe H; Foo TH; Djazaeri B; Duncombe P; Mackay IS; Durham SR
    Rhinology; 2003 Sep; 41(3):167-74. PubMed ID: 14579657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ultrastructural changes in human nasal mucosa in rhinitis medicamentosa].
    Knipping S; Holzhausen HJ; Riederer A; Bloching M
    HNO; 2006 Oct; 54(10):742-8. PubMed ID: 16477462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mometasone furoate nasal spray plus oxymetazoline nasal spray: short-term efficacy and safety in seasonal allergic rhinitis.
    Meltzer EO; Bernstein DI; Prenner BM; Berger WE; Shekar T; Teper AA
    Am J Rhinol Allergy; 2013; 27(2):102-8. PubMed ID: 23562197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Not Available].
    Munksgaard JB; Christensen JJ; Aanæs K
    Ugeskr Laeger; 2024 Sep; 186(36):. PubMed ID: 39320073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe Rhinitis Medicamentosa Successfully Treated with Rhinolight® Endonasal UV Phototherapy.
    Carson P; Lyons M
    Ir Med J; 2019 Feb; 112(2):874. PubMed ID: 30875167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Research progress on rhinitis medicamentosa].
    Wang YN; Luan ZL; Wang HT
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Nov; 52(11):872-875. PubMed ID: 29141305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rise and fall of decongestants in treating nasal congestion related diseases.
    Wang J; Mao ZF; Cheng L
    Expert Opin Pharmacother; 2024 Oct; 25(14):1943-1951. PubMed ID: 39344778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended use of topical nasal decongestants.
    Yoo JK; Seikaly H; Calhoun KH
    Laryngoscope; 1997 Jan; 107(1):40-3. PubMed ID: 9001263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-medication in persistent rhinitis: overuse of decongestants in half of the patients.
    Mehuys E; Gevaert P; Brusselle G; Van Hees T; Adriaens E; Christiaens T; Van Bortel L; Van Tongelen I; Remon JP; Boussery K
    J Allergy Clin Immunol Pract; 2014; 2(3):313-9. PubMed ID: 24811023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased frequency of rhinitis medicamentosa due to media advertising for nasal topical decongestants.
    Archontaki M; Symvoulakis EK; Hajiioannou JK; Stamou AK; Kastrinakis S; Bizaki AJ; Kyrmizakis DE
    B-ENT; 2009; 5(3):159-62. PubMed ID: 19902852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rhinitis medicamentosa].
    Ostroumova OD; Shikh EV; Rebrova EV; Ryazanova AY
    Vestn Otorinolaringol; 2020; 85(3):75-82. PubMed ID: 32628388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should Excess Topical Decongestant Use Raise a Red Flag? Rhinitis Medicamentosa and Opioid Use Disorder.
    Patel A; Levi JR; Brook CD
    Ann Otol Rhinol Laryngol; 2020 Feb; 129(2):164-169. PubMed ID: 31581795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.